U.S. guidance on Section 301 China COVID-19 product exclusion extensions
Instructions for importers, brokers, and filers on submitting entries to CBP
Instructions for importers, brokers, and filers on submitting entries to CBP
U.S. Customs and Border Protection (CBP) today issued guidance concerning COVID-19-related duties and product exclusions under the Section 301 investigation of China’s acts, policies, and practices related to technology transfer, intellectual property, and innovation.
Background
The Office of the United States Trade Representative (USTR) in May 2023 issued a notice extending through September 30, 2023, 77 of 81 COVID-19-related exclusions in the China Section 301 investigation. The exclusions were previously scheduled to expire on May 15, 2023. The USTR also extended all 81 COVID-19-related exclusions, through May 31, 2023, to allow for a transition period. Read TradeNewsFlash
CBP guidance
Today’s guidance—CSMS # 56517869—provides instructions for importers, brokers, and filers on submitting entries to CBP containing granted COVID-19-related exclusions by the USTR from the Section 301 measures.
For more information, contact a professional with KPMG’s Trade & Customs services:
Doug Zuvich |
John L. McLoughlin |
Andy Siciliano |
Steve Brotherton |
Luis (Lou) Abad |
Irina Vaysfeld |
Amie Ahanchian |
Christopher Young |
Gisele Belotto |
George Zaharatos |
Andy Doornaert |
Jessica Libby Principal E: jlibby@kpmg.com |
| John Anderson Managing Director E: johneanderson@kpmg.com |
Jenna Leigh Glass Managing Director E: jennaleighglass@kpmg.com |
The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 3712, 1801 K Street NW, Washington, DC 20006.